scispace - formally typeset
S

Susan C. Morpeth

Researcher at Middlemore Hospital

Publications -  26
Citations -  2455

Susan C. Morpeth is an academic researcher from Middlemore Hospital. The author has contributed to research in topics: Randomized controlled trial & Hydroxychloroquine. The author has an hindex of 12, co-authored 26 publications receiving 1510 citations. Previous affiliations of Susan C. Morpeth include Durham University & Duke University.

Papers
More filters
Journal ArticleDOI

A minimal common outcome measure set for COVID-19 clinical research

John Marshall, +62 more
TL;DR: A minimum set of common outcome measures for studies of COVID-19, which includes a measure of viral burden, patient survival, and patient progression through the health-care system by use of the WHO Clinical Progression Scale are urged.
Journal ArticleDOI

Invasive Non-Typhi Salmonella Disease in Africa

TL;DR: The clinical presentation of non-Typhi Salmonella bacteremia is nonspecific and, in the absence of blood culture, may be confused with other febrile illnesses, such as malaria.
Journal ArticleDOI

Non-HACEK gram-negative bacillus endocarditis.

Susan C. Morpeth, +240 more
TL;DR: The ICE-PCS database offers a unique opportunity to evaluate the epidemiology, characteristics, and outcome of endocarditis due to non-HACEK gram-negative bacilli in a large, contemporary, and international cohort of well-characterized patients withendocarditis.
Journal ArticleDOI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more
TL;DR: In this article, a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients was presented.